[Federal Register Volume 87, Number 233 (Tuesday, December 6, 2022)]
[Proposed Rules]
[Pages 74535-74537]
[FR Doc No: 2022-26471]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2022-1572; Project Identifier MCAI-2022-00350-T]
RIN 2120-AA64

Airworthiness Directives; Bombardier, Inc. Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: The FAA proposes to adopt a new airworthiness directive (AD)
for all Bombardier, Inc., Model CL-600-1A11 (600), CL-600-2A12 (601),
and CL-600-2B16 (601-3A, 601-3R, and 604 Variants) airplanes. This
proposed AD was prompted by a determination that, due to a lack of
flightcrew awareness, smoke hoods with a certain part number installed
throughout the airplane could be mistaken for protective breathing
equipment (PBE). This proposed AD would require an inspection or
records review to determine if any smoke hood with a certain part
number is installed in any location on the airplane and, depending on
the results, removing the smoke hood and associated placards and
installing new placards. The FAA is proposing this AD to address the
unsafe condition on these products.

DATES: The FAA must receive comments on this proposed AD by January 20,
2023.

ADDRESSES: You may send comments, using the procedures found in 14 CFR
11.43 and 11.45, by any of the following methods:
     Federal eRulemaking Portal: Go to regulations.gov. Follow
the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE, Washington, DC 20590.
     Hand Delivery: Deliver to Mail address above between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    AD Docket: You may examine the AD docket at regulations.gov under
Docket No. FAA-2022-1572; or in person at Docket Operations between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays. The AD
docket contains this NPRM, the mandatory continuing airworthiness
information (MCAI), any comments received, and other information. The
street address for Docket Operations is listed above.
    Material Incorporated by Reference:
     For service information identified in this NPRM, contact
Bombardier Business Aircraft Customer Response Center, 400 C[ocirc]te-
Vertu Road West, Dorval, Qu[eacute]bec H4S 1Y9, Canada; telephone 514-
855-2999; email bombardier.com">[email protected]bombardier.com; website: bombardier.com.
     You may view this service information at the FAA,
Airworthiness Products Section, Operational Safety Branch, 2200 South
216th St., Des Moines, WA. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Chirayu Gupta, Aerospace Engineer,
Mechanical Systems and Administrative Services Section, FAA, New York
ACO Branch, 1600 Stewart Avenue, Suite 410, Westbury, NY 11590;
telephone<PHONE_NUMBER>; email [email protected].

SUPPLEMENTARY INFORMATION:

Comments Invited

    The FAA invites you to send any written relevant data, views, or
arguments about this proposal. Send your comments to an address listed
under ADDRESSES. Include ``Docket No. FAA-2022-1572; Project Identifier
MCAI-2022-00350-T'' at the beginning of your comments. The most helpful
comments reference a specific portion of the proposal, explain the
reason for any recommended change, and include supporting data. The FAA
will consider all comments received by the closing date and may amend
the proposal because of those comments.
    Except for Confidential Business Information (CBI) as described in
the following paragraph, and other information as described in 14 CFR
11.35, the FAA will post all comments received, without change, to
regulations.gov, including any personal information you provide. The
agency will also post a report summarizing each substantive verbal
contact received about this NPRM.

Confidential Business Information

    CBI is commercial or financial information that is both customarily
and actually treated as private by its owner. Under the Freedom of
Information Act (FOIA) (5 U.S.C. 552), CBI is exempt from public
disclosure. If your comments responsive to this NPRM contain commercial
or financial information that is customarily treated as private, that
you actually treat as private, and that is relevant or responsive to
this NPRM, it is important that you clearly designate the submitted
comments as CBI. Please mark each page of your submission containing
CBI as ``PROPIN.'' The FAA will treat such marked submissions as
confidential under the FOIA, and they will not be placed in the public
docket of this NPRM. Submissions containing CBI should be sent to
Chirayu Gupta, Aerospace Engineer, Mechanical Systems and
Administrative Services Section, FAA, New York ACO Branch, 1600 Stewart
Avenue, Suite 410, Westbury, NY 11590; telephone<PHONE_NUMBER>; email [email protected]. Any commentary that the FAA receives which is
not specifically

designated as CBI will be placed in the public docket for this
rulemaking.

Background

    Transport Canada, which is the aviation authority for Canada, has
issued Transport Canada AD CF-2022-10, dated March 10, 2022 (Transport
Canada AD CF-2022-10) (also referred to after this as the MCAI), to
correct an unsafe condition on all Bombardier, Inc. Model CL-600-1A11,
CL-600-2A12, and CL-600-2B16 airplanes. The MCAI states that
Bombardier, Inc., determined that, due to a lack of flightcrew
awareness, smoke hoods with a certain part number installed throughout
the airplane could be mistaken for PBE. The MCAI requires that
operators verify if a smoke hood with a certain part number is
installed in any location on the airplane and, depending on the
results, removing the smoke hood and associated placards and installing
new placards. The MCAI states that in a fire or smoke event the
flightcrew might initially attempt to use the smoke hood believing it
to be PBE, which could result in a delay in identifying the source of
the smoke or fire.
    You may examine the MCAI in the AD docket at regulations.gov under
Docket No. FAA-2022-1572.

Related Service Information Under 1 CFR Part 51

    The FAA reviewed the following Bombardier, Inc. service
information, which specify procedures to verify (via inspection or
records review) if any smoke hood having part number MR-10008N is
installed in the flight deck, forward wardrobe or any location on the
airplane, removing any affected smoke hood and associated placards, and
installing new placards. These documents are distinct since they apply
to different airplane models and configurations.
     Bombardier Service Bulletin 600-0778, dated September 22,
2021.
     Bombardier Service Bulletin 601-1110, dated September 22,
2021.
     Bombardier Service Bulletin 604-25-004, dated September
22, 2021.
     Bombardier Service Bulletin, 605-25-014, dated September
22, 2021.
     Bombardier Service Bulletin, 650-25-016, dated September
22, 2021.
    This service information is reasonably available because the
interested parties have access to it through their normal course of
business or by the means identified in the ADDRESSES section.

FAA's Determination

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to the FAA's bilateral agreement with this State of Design Authority,
it has notified the FAA of the unsafe condition described in the MCAI
and service information described above. The FAA is issuing this NPRM
after determining that the unsafe condition described previously is
likely to exist or develop on other products of the same type design.

Proposed AD Requirements in This NPRM

    This proposed AD would require accomplishing the actions specified
in the service information already described.

Costs of Compliance

    The FAA estimates that this AD, if adopted as proposed, would
affect 698 airplanes of U.S. registry. The FAA estimates the following
costs to comply with this proposed AD:

                                      Estimated Costs for Required Actions
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per      Cost on U.S.
                             Labor cost                               Parts cost      product       operators
----------------------------------------------------------------------------------------------------------------
1 work-hour x $85 per hour = $85...................................           $0           $85          $59,330
----------------------------------------------------------------------------------------------------------------

    The FAA estimates the following costs to do any necessary on-
condition actions that would be required based on the results of any
required actions. The FAA has no way of determining the number of
aircraft that might need these on-condition actions:

                 Estimated Costs of On-Condition Actions
------------------------------------------------------------------------
                                                             Cost per
              Labor cost                   Parts cost        product
------------------------------------------------------------------------
1 work-hour x $85 per hour = $85......              $9              $94
------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: General requirements.
Under that section, Congress charges the FAA with promoting safe flight
of civil aircraft in air commerce by prescribing regulations for
practices, methods, and procedures the Administrator finds necessary
for safety in air commerce. This regulation is within the scope of that
authority because it addresses an unsafe condition that is likely to
exist or develop on products identified in this rulemaking action.

Regulatory Findings

    The FAA determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Would not affect intrastate aviation in Alaska, and
    (3) Would not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive:

Bombardier, Inc.: Docket No. FAA-2022-1572; Project Identifier MCAI-
2022-00350-T.

(a) Comments Due Date

    The FAA must receive comments on this airworthiness directive
(AD) by January 20, 2023.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to all Bombardier, Inc., airplanes, certificated
in any category, as identified in paragraphs (c)(1) through (3) of
this AD.
    (1) Model CL-600-1A11 (600) airplanes.
    (2) Model CL-600-2A12 (601) airplanes.
    (3) Model CL-600-2B16 (601-3A, 601-3R, and 604 Variants)
airplanes.

(d) Subject

    Air Transport Association (ATA) of America Code 25, Equipment/
furnishings.

(e) Unsafe Condition

    This AD was prompted by a determination that, due to a lack of
flightcrew awareness, smoke hoods with a certain part number
installed throughout the airplane could be mistaken for protective
breathing equipment (PBE). The FAA is issuing this AD to address, in
a fire or smoke event, that the flightcrew might initially
attempting to use the smoke hood believing it to be PBE. The unsafe
condition, if not addressed, could result in a delay in identifying
the source of the smoke or fire.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Inspection

    Within 12 months after the effective date of this AD: Do an
inspection to determine if any smoke hood having part number (P/N)
MR-10008N is installed in the flight deck, forward wardrobe, or any
other location in the airplane. A review of airplane maintenance
records is acceptable in lieu of this inspection if the part number
of the smoke hood can be conclusively determined from that review.

(h) Corrective Action

    If, during the inspection or records review required by
paragraph (g) of this AD, any smoke hood having P/N MR-10008N is
found on the airplane, within 12 months after the effective date of
this AD, remove the smoke hood, including any associated placards,
and install a new placard, in accordance with Section 2.B. of the
Accomplishment Instructions of the applicable Bombardier service
bulletin specified in paragraphs (h)(1) through (5) of this AD; or
the method specified in paragraph (h)(6) of this AD; as applicable.
    (1) For Model CL-600-1A11 (600) airplanes: Bombardier Service
Bulletin 600-0778, dated September 22, 2021.
    (2) For Model CL-600-2A12 (601) airplanes: Bombardier Service
Bulletin 601-1110, dated September 22, 2021.
    (3) For Model CL-600-2B16 airplanes (604 variant) with serial
numbers 5301 through 5644 inclusive: Bombardier Service Bulletin
604-25-004, dated September 22, 2021.
    (4) For Model CL-600-2B16 (604 variant) airplanes with serial
numbers 5701 through 5988 inclusive: Bombardier Service Bulletin
605-25-014, dated September 22, 2021.
    (5) For Model CL-600-2B16 airplanes (604 variant) with serial
numbers 6050 through 6099 inclusive: Bombardier Service Bulletin
650-25-016, dated September 22, 2021.
    (6) For Model CL-600-2B16 (601-3A and 601-3R Variants)
airplanes: A method approved by the Manager, New York ACO Branch,
FAA; or Transport Canada; or Bombardier, Inc.'s Transport Canada
Design Approval Organization (DAO). If approved by the DAO, the
approval must include the DAO-authorized signature.

(i) Additional AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager, New
York ACO Branch, FAA, has the authority to approve AMOCs for this
AD, if requested using the procedures found in 14 CFR 39.19. In
accordance with 14 CFR 39.19, send your request to your principal
inspector or responsible Flight Standards Office, as appropriate. If
sending information directly to the manager of the New York ACO
Branch, mail it to ATTN: Program Manager, Continuing Operational
Safety, at the address identified in paragraph (j)(2) of this AD or
email to: [email protected]. If mailing information, also
submit information by email. Before using any approved AMOC, notify
your appropriate principal inspector, or lacking a principal
inspector, the manager of the responsible Flight Standards Office.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain instructions from a manufacturer, the instructions must be
accomplished using a method approved by the Manager, New York ACO
Branch, FAA; or Transport Canada; or Bombardier, Inc.'s Transport
Canada Design Approval Organization (DAO). If approved by the DAO,
the approval must include the DAO-authorized signature.

(j) Additional Information

    (1) Refer to Transport Canada AD CF-2022-10, dated March 10,
2022, for related information. This Transport Canada AD may be found
in the AD docket at regulations.gov under Docket No. FAA-2022-1572.
    (2) For more information about this AD, contact Chirayu Gupta,
Aerospace Engineer, Mechanical Systems and Administrative Services
Section, FAA, New York ACO Branch, 1600 Stewart Avenue, Suite 410,
Westbury, NY 11590; telephone<PHONE_NUMBER>; email [email protected].

(k) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference (IBR) of the service information listed
in this paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless this AD specifies otherwise.
    (i) Bombardier Service Bulletin 600-0778, dated September 22,
2021.
    (ii) Bombardier Service Bulletin 601-1110, dated September 22,
2021.
    (iii) Bombardier Service Bulletin 604-25-004, dated September
22, 2021.
    (iv) Bombardier Service Bulletin, 605-25-014, dated September
22, 2021.
    (v) Bombardier Service Bulletin, 650-25-016, dated September 22,
2021.
    (3) For service information identified in this AD, contact
Bombardier Business Aircraft Customer Response Center, 400
C[ocirc]te-Vertu Road West, Dorval, Qu[eacute]bec H4S 1Y9, Canada;
telephone<PHONE_NUMBER>; email bombardier.com">[email protected]bombardier.com; website:
bombardier.com.
    (4) You may view this service information at the FAA,
Airworthiness Products Section, Operational Safety Branch, 2200
South 216th St., Des Moines, WA. For information on the availability
of this material at the FAA, call<PHONE_NUMBER>.
    (5) You may view this service information that is incorporated
by reference at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, email [email protected], or go to: www.archives.gov/federal-register/cfr/ibr-locations.html.

    Issued on December 1, 2022.
Christina Underwood,
Acting Director, Compliance & Airworthiness Division, Aircraft
Certification Service.
[FR Doc. 2022-26471 Filed 12-5-22; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register: August 16, 2006 (Volume 71, Number 158)]
[Rules and Regulations]
[Page 47101-47106]
[DOCID:fr16au06-16]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2005-0018; FRL-8080-7]

Endothall; Pesticide Tolerance

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes a tolerance for combined residues
of endothall and its monomethyl ester in or on fish. Cerexagri, Inc.
requested this tolerance under the Federal Food, Drug, and Cosmetic Act
(FFDCA), as amended by the Food Quality Protection Act of 1996 (FQPA).

DATES: This regulation is effective August 16, 2006. Objections and
requests for hearings must be received on or before October 16, 2006,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2005-0018. All documents in the
docket are listed in the index for the docket. Although listed in the
index, some information is not publicly available, e.g., Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Certain other material, such as copyrighted
material, is not placed on the Internet and will be publicly available
only in hard copy form. Publicly available docket materials are
available in the electronic docket at http://www.regulations.gov, or,

if only available in hard copy, at the OPP Regulatory Public Docket in
Rm. S-4400, One Potomac Yard (South Building), 2777 S. Crystal Drive,
Arlington, VA. The Docket Facility is open from 8:30 a.m. to 4 p.m.,
Monday through Friday, excluding legal holidays. The Docket telephone
number is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Joanne Miller, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone
number:<PHONE_NUMBER>; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
     Crop production (NAICS 111), e.g., agricultural workers;
greenhouse, nursery, and floriculture workers; farmers.
     Animal production (NAICS 112), e.g., cattle ranchers and
farmers, dairy cattle farmers, livestock farmers.
     Food manufacturing (NAICS 311), e.g., agricultural
workers; farmers; greenhouse, nursery, and floriculture workers;
ranchers; pesticide applicators.
     Pesticide manufacturing (NAICS 32532), e.g., agricultural
workers; commercial applicators; farmers; greenhouse, nursery, and
floriculture workers; residential users.
    This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.

B. How Can I Access Electronic Copies of this Document?

    In addition to accessing an electronic copy of this Federal
Register document through the electronic docket at http://www.regulations.gov
, you may access this Federal Register document

electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr. You may also access a

frequently updated electronic version of 40 CFR part 180 through the
Government Printing Office's pilot e-CFR site at http://www.gpoaccess.gov/ecfr.
 To access the OPPTS Harmonized Guidelines

referenced in this document, go directly to the guidelines at http://www.epa.gpo/opptsfrs/home/guidelin.htm

C. Can I File an Objection or Hearing Request?

    Under section 408(g) of the FFDCA, as amended by the FQPA, any
person may file an objection to any aspect of this regulation and may
also request a hearing on those objections. The EPA procedural
regulations which govern the submission of objections and requests for
hearings appear in 40 CFR part 178. You must file your objection or
request a hearing on this regulation in accordance with the
instructions provided in 40 CFR part 178. To ensure proper receipt by
EPA, you must identify docket ID number EPA-HQ-OPP-2005-0018 in the
subject line on the first page of your submission. All requests must be
in writing, and must be mailed or delivered to the Hearing Clerk on or
before October 16, 2006.
    In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket that is described in ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice. Submit your copies, identified by docket ID
number EPA-HQ-OPP-2005-0018, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.

Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Building), 2777 S. Crystal Drive, Arlington, VA. Deliveries are only
accepted during the Docket's normal hours of operation (8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays). Special
arrangements should be made for deliveries of boxed information. The
Docket telephone number is<PHONE_NUMBER>.

II. Background and Statutory Findings

    In the Federal Register of February 11, 2005 (70 FR 7260) (FRL-
7696-9), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
9F6015) by Cerexagri, Inc., 630 Freedom Business Center, Suite 402,
King of Prussia, PA 19406. The petition requested that 40 CFR 180.293
be amended by establishing a tolerance for residues of the herbicide
endothall, 7-oxabicyclo[2,2,1] heptane-2,3-dicarboxylic acid, in or on
fish/shellfish at 0.25 parts per million (ppm). That notice included a
summary of the petition prepared by Cerexagri, Inc., the registrant.
Comments were received on the notice of filing. EPA's response to these
comments is discussed in Unit IV.C. On June 8, 2006, Cerexagri, Inc.
submitted a revised petition to the Agency. The petition was requested
establishing a tolerance for endothall in or on fish at 0.1 ppm.

    The endothall tolerance under 40 CFR 180.293 is being revised per
the Endothall RED, to be expressed in terms of endothall per se and its
monomethyl ester. Tolerances that are currently established for
residues in/on undelinted cotton seed, hops, potato, and rice grain and
straw will not change in value.
    Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical
residue....''
    EPA performs a number of analyses to determine the risks from
aggregate exposure to pesticide residues. For further discussion of the
regulatory requirements of section 408 of the FFDCA and a complete
description of the risk assessment process, see http://www.epa.gov/fedrgstr/EPA-PEST/1997/November/Day-26/p30948.htm
.

III. Aggregate Risk Assessment and Determination of Safety

    Consistent with section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action. EPA has sufficient data to assess the hazards of and to
make a determination on aggregate exposure, consistent with section
408(b)(2) of FFDCA, for a tolerance for combined residues of endothall
and its monomethyl ester on fish at 0.1 ppm. EPA's assessment of
exposures and risks associated with establishing the tolerance follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children. Specific information on the studies received and the nature
of the toxic effects caused by endothall and its monomethyl ester as
well as the no-observed-adverse-effect-level (NOAEL) and the lowest-
observed-adverse-effect-level (LOAEL) from the toxicity studies can be
found at http://www.epa.gov/oppsrrd1/REDs/endothall_red.pd.

B. Toxicological Endpoints

    For hazards that have a threshold below which there is no
appreciable risk, the NOAEL from the toxicology study identified as
appropriate for use in risk assessment is used to estimate the
toxicological level of concern (LOC). However, the LOAEL is sometimes
used for risk assessment if no NOAEL was achieved in the toxicology
study selected. An uncertainty factor (UF) is applied to reflect
uncertainties inherent in the extrapolation from laboratory animal data
to humans and in the variations in sensitivity among members of the
human population as well as other unknowns.
    The linear default risk methodology (Q*) is the primary method
currently used by the Agency to quantify non-threshold hazards such as
cancer. The Q* approach assumes that any amount of exposure will lead
to some degree of cancer risk, estimates risk in terms of the
probability of occurrence of additional cancer cases. More information
can be found on the general principles EPA uses in risk
characterization at http://www.epa.gov/pesticides/health/human.htm.

    A summary of the toxicological endpoints for endothall and its
monomethyl ester used for human risk assessment is shown in Table 1 of
this unit:

  Table 1.--Summary of Toxicological Dose and Endpoints for Endothall and its monomethyl ester for Use in Human
                                                 Risk Assessment
----------------------------------------------------------------------------------------------------------------
                                          Dose Used in Risk
                                             Assessment,          Special FQPA Safety
          Exposure/Scenario                Interspecies and     Factor (SF) and LOC for  Study and Toxicological
                                         Intraspecies and any       Risk Assessment              Effects
                                            Traditional UF
----------------------------------------------------------------------------------------------------------------
Acute Dietary (Females 13-50 years of                                                    An appropriate endpoint
 age)                                                                                attributable to a
                                                                                single dose was not
                                                                                available from any
                                                                                study, including the
                                                                                prenatal developmental
                                                                                toxicity study in
                                                                                rats. An acute
                                                                                reference dose (RfD)
                                                                                was not established.
----------------------------------------------------------------------------------------------------------------
Chronic Dietary (All populations)      LOAEL= 2 milligrams/     FQPA SF = 1              Rat 2-generation
                                        kilogram (mg/kg)/day    Chronic population        reproduction study
                                       UF = 300...............   adjusted dose (cPAD) =  LOAEL 2 mg/kg/day based
                                       Chronic RfD = 0.007 mg/   chronic RfD / FQPA SF.   on proliferative
                                        kg/day.                 = 0.007 mg/kg/day......   lesions of the gastric
                                                                                epithelium (both
                                                                                sexes)
----------------------------------------------------------------------------------------------------------------
Short-Term Incidental Oral (1 to 30    Offspring                Residential LOC for      Rat 2-generation
 days) (Residential)                   NOAEL = 9.4 mg/kg/day..   Margin of Exposure       reproduction study
                                                                 (MOE) = 100             LOAEL 60 mg/kg/day
                                                                Occupational = Not        based on decreased pup
                                                                 Applicable (N.A.).       body weight (both
                                                                                sexes) on Day 0 F1 and
                                                                                F2 generations
----------------------------------------------------------------------------------------------------------------
Intermediate-Term Incidental Oral (1   LOAEL= 2 mg/kg/day       Residential LOC for MOE  Rat 2-generation
 to 6 months) (Residential)                                      = 300                    reproduction study
                                                                Occupational = N.A.....  LOAEL 2 mg/kg/day based
                                                                                on proliferative
                                                                                lesions of the gastric
                                                                                epithelium (both
                                                                                sexes)
----------------------------------------------------------------------------------------------------------------

Short-Term Dermal (1 to 30 days)                                                         No dermal assessments
 (Residential)                                                                            were conducted, since
                                                                                endothall is a severe
                                                                                dermal irritant and
                                                                                repeated dermal
                                                                                exposure is highly
                                                                                unlikely to occur.
----------------------------------------------------------------------------------------------------------------
Intermediate-Term Dermal (1 to 6                                                         No dermal assessments
 months) (Residential)                                                                    were conducted, since
                                                                                endothall is a severe
                                                                                dermal irritant and
                                                                                repeated dermal
                                                                                exposure is highly
                                                                                unlikely to occur.
----------------------------------------------------------------------------------------------------------------
Long-Term Dermal (>6 months)           N.A. No exposure under   Residential N.A.         N.A.
                                        use pattern             Occupational N.A.......
----------------------------------------------------------------------------------------------------------------
Short-Term Inhalation (1 to 30 days)   Offspring                Residential LOC for MOE  Rat 2-generation
                                       NOAEL = 9.4 mg/kg/day     = 100                    reproduction study
                                        (inhalation absorption  Occupational LOC for     LOAEL 60 mg/kg/day
                                        rate = 100%).            MOE = 100.               based on decreased pup
                                                                                body weight (both
                                                                                sexes) on Day 0 F1 and
                                                                                F2 generations
----------------------------------------------------------------------------------------------------------------
Intermediate-Term Inhalation (1 to 6   LOAEL= 2 mg/kg/day       Residential LOC for MOE  Rat 2-generation
 months) and Long-Term Inhalation (>6                            = 300                    reproduction study
 months)                                                        Occupational LOC for     LOAEL 2 mg/kg/day based
                                                                 MOE = 300.               on proliferative
                                                                                lesions of the gastric
                                                                                epithelium (both
                                                                                sexes)
----------------------------------------------------------------------------------------------------------------
Cancer (oral, dermal, inhalation)      N.A....................  N.A....................  Chronic/Onco Rat
                                                                                Negative for
                                                                                carcinogenicity
                                                                                Carcinogenicity Mice
                                                                                Negative for
                                                                                carcinogenicity
                                                                                Not likely carcinogenic
                                                                                to humans
----------------------------------------------------------------------------------------------------------------

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. Tolerances have been
established (40 CFR 180.293) for the residues of endothall, in or on a
variety of raw agricultural commodities. Risk assessments were
conducted by EPA to assess dietary exposures from endothall and its
monomethyl ester in food as follows:
    i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a one-day or single exposure.
    No such effects were identified in the toxicological studies for
endothall and its monomethyl ester; therefore, a quantitative acute
dietary exposure assessment is unnecessary. In conducting the acute
dietary exposure assessment EPA used the Dietary Exposure Evaluation
Model software with the Food Commodity Intake Database (DEEM-FCID\TM\),
which incorporates food consumption data as reported by respondents in
the United States Department of Agricultural (USDA) 1994-1996 and 1998
Nationwide Continuing Surveys of Food Intake by Individuals (CSFII),
and accumulated exposure to the chemical for each commodity. The
following assumptions were made for the acute exposure assessments: No
toxicological endpoint was identified for acute oral exposure.
Therefore no acute dietary exposure assessment was performed.
    ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the DEEM-FCID\TM\, which incorporates food
consumption data as reported by respondents in the USDA 1994-1996 and
1998 Nationwide CSFII, and accumulated exposure to the chemical for
each commodity. The following assumptions were made for the chronic
exposure assessments: For the chronic analyses, tolerance-level
residues were assumed for all food commodities with current or proposed
endothall tolerances, and it was assumed that all the crops included in
the analysis were treated. Percent Crop Treated (PCT) and/or
anticipated residues were not used in the chronic risk assessment.
    iii. Cancer. Endothall is considered not likely to be carcinogenic
to humans.
    2. Dietary exposure from drinking water. This assessment assumes an
endothall concentration of 100 parts per billion (ppb) as the average
concentration in drinking water. This concentration is the Maximum
Contaminant Level (MCL) for endothall. Actual monitoring data for
endothall suggest the average concentration of endothall in drinking
water are well below the MCL. Monitoring data for finished water are
available from the National Contaminant Occurrence Database (NCOD) for
both surface water and ground water. Detectable residues of endothall
were found in only 7 of 27,494 or 0.025% of ground water samples and 8
of 5,112 or 0.15% of surface water samples. Although these few values
are above the established Maximum Contaminant Level (MCL) for endothall
of 100 ppb, greater than 99% of ground water and surface water samples
contained concentration below the limit of detections (10 ppb). Using
this data the mean concentration of endothall would be expected to be
10 ppb in both ground water and surface water. Although the MCL is
likely to overestimate average (i.e., chronic) residues of endothall in
drinking water,

EPA believes it provides a reasonable high-end estimate of potential
drinking water concentrations from the aquatic uses of endothall.
Consequently, the MCL of 100 ppb was used in the dietary risk
assessment.
    Based on the Pesticide Root Zone Model/Exposure Analysis Modeling
System (PRZM/EXAMS) and Screening Concentration in Ground Water (SCI-
GROW) models, the estimated environmental concentrations (EECs) of
endothall and its monomethyl ester for acute exposures are estimated to
be 7.1 ppb for surface water and 0.086 ppb for ground water. The EECs
for chronic exposures are estimated to be 2.5 ppb for surface water and
0.086 ppb for ground water. The EECs for chronic exposures (cancer) are
estimated to be 2.4 ppb for surface water and 0.086 ppb for ground
water.
    3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets). Endothall and its
monomethyl ester is currently registered for use on the following
residential non-dietary sites: Ponds and garden pools. The risk
assessment was conducted using the following residential exposure
assumptions: Homeowners may potentially be exposed to endothall by
applying home-use formulations. There is potential for exposure to
adults and children from incidental oral and dermal exposure during
recreational activities in public waters treated with endothall.
    As a result, risk assessments were completed for both residential
handlers and post-application scenarios. Residential applications are
only expected to occur over short-periods of time. For residential
post-application exposures, exposures on the day of application after
an application to a public water body are of the greatest concern. The
Agency identified incidental oral exposure (from swallowing water while
swimming) and the potential for dermal irritation while swimming as
possible post-application exposure scenarios. The Agency conducted an
assessment, using the SWIM modeling program, to assess incidental
exposures. Risks were calculated using MOEs, where and MOE greater than
or equal to 100 is below EPA's LOC.
    4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of the FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
    Unlike other pesticides for which EPA has followed a cumulative
risk approach based on a common mechanism of toxicity, EPA has not made
a common mechanism of toxicity finding as to endothall and its
monomethyl ester and any other substances and endothall and its
monomethyl ester does not appear to produce a toxic metabolite produced
by other substances. For the purposes of this tolerance action,
therefore, EPA has not assumed that endothall and its monomethyl ester
has a common mechanism of toxicity with other substances. For
information regarding EPA's efforts to determine which chemicals have a
common mechanism of toxicity and to evaluate the cumulative effects of
such chemicals, see the policy statements released by EPA's Office of
Pesticide Programs concerning common mechanism determinations and
procedures for cumulating effects from substances found to have a
common mechanism on EPA's website at http://www.epa.gov/pesticides/cumulative
.

D. Safety Factor for Infants and Children

    1. In general. Section 408 of FFDCA provides that EPA shall apply
an additional tenfold margin of safety for infants and children in the
case of threshold effects to account for prenatal and postnatal
toxicity and the completeness of the data base on toxicity and exposure
unless EPA determines based on reliable data that a different margin of
safety will be safe for infants and children. Margins of safety are
incorporated into EPA risk assessments either directly through use of a
MOE analysis or through using uncertainty (safety) factors in
calculating a dose level that poses no appreciable risk to humans. In
applying this provision, EPA either retains the default value of 10X
when reliable data do not support the choice of a different factor, or,
if reliable data are available, EPA uses a different additional safety
factor value based on the use of traditional UFs and/or special FQPA
safety factors, as appropriate.
    2. Prenatal and postnatal sensitivity. There is not a concern for
prenatal and/or postnatal toxicity resulting from exposure to endothall
in rats (rabbit- not yet determined). There was no quantitative or
qualitative evidence of increased susceptibility following prenatal
exposure to rats in the developmental toxicity study and prenatal/
postnatal exposure to rats in the 2-generation reproduction study. Due
to the lack of a prenatal developmental study in rabbits,
susceptibility could not be ascertained in a second (non-rodent)
species.
    There are no concerns for residual uncertainty for prenatal
toxicity in the available developmental study, or the 2-generation rat
toxicity study. In evaluating the toxicological database for endothall,
the primary effects are the point of entry effects (i.e., dermal). In
addition, the weight of evidence suggests that endothall will be of no
developmental concern. The rabbit developmental study is being required
as a confirmatory study.
    3. Conclusion. Based on the above data base (which is considered
adequate), no special FQPA safety factor (i.e. 1X) is required since
there are no residual uncertainties for prenatal toxicity. In deriving
uncertainty for use in the risk assessment, the conventional 10x factor
for interspecies extrapolation and 10x for intraspecies extrapolation
were used for all scenarios. The data base was complete enough and
there was no evidence of prenatal or postnatal susceptibility in the
studies submitted and evaluated to date. Therefore, the FQPA 10X factor
was reduced to 1X. The exposure scenarios in which the hazard value was
based on a LOAEL (intermediate term inhalation for both occupational
and residential settings) an additional UF of 3X was used to
approximate a NOAEL.

E. Aggregate Risks and Determination of Safety

    1. Acute risk. Due to the lack of an acute Rfd and acute dietary
exposure/risk, an acute aggregate risk assessment was not performed.
    2. Chronic risk. There are no long term residential uses of
endothall. Aggregated chronic exposures to endothall through food plus
drinking water were calculated in DEEM\TM\. The results for directly
treated crops, irrigated crops and drinking water from aquatic uses of
endothall were 33% of the cPAD (0.002297 mg/kg/day) for the general
population. The most highly exposed population subgroup was infants at
103% cPAD (0.007234 mg/kg/day). This risk estimate is the result of
conservative assumptions (using the MCL of 100 ppb, likely to
overestimate chronic residues of endothall in drinking waters).
    3. Short-term risk. A risk assessment for aggregate exposures (food
+ drinking water + residential) was conducted for the short term
exposure scenario because residential uses of endothall are expected to
be only episodic. Food

exposures are based on treated crops and irrigated crops. Drinking
water exposures are based on aquatic uses of endothall. Although
endothall has terrestrial uses, as well as aquatic uses, the aquatic
uses result in the highest estimates of potential drinking water
exposures. Residential handler exposures for adults are based on
granular applications of endothall with a belly grinder to lakes or
ponds. Residential post-application exposures for adults and children
are based on swimming.
    For adults, estimated dietary exposures via food and drinking water
were combined with inhalation exposures during application to a pond or
lake and potential post-application exposures during swimming. The
Agency notes the handler scenario aggregated for adults is the exposure
scenario resulting in the lowest MOE (highest risk estimate) for
residential handlers. For children, estimated dietary exposures via
food and drinking water were combined with potential post-application
exposures during swimming. The short term aggregate risk estimate (MOE)
for adults is 310, for children, it is 250. The MOEs are not a risk
concern. Therefore, there are no short term aggregate (food + drinking
water + residential) risk concerns for endothall.

                            Table 2.--Aggregate Risk Assessment for Short-Term Exposure to Endothall and its monomethyl ester
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Short Term Scenario
                                                                   -------------------------------------------------------------------------------------
                                                                                Residential
                            Population                                 Target     MOE food + -----------------------------------------   Aggregate MOE
                                                                     Aggregate     water\2\                                  MOE       (food + water and
                                                                       MOE\1\                 MOE oral\3\   MOE dermal  inhalation\4\   residential)\5\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Child (3-5 years old)                                                       100        2,770          280         N.A.          N.A.                 250
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adults (50+ years old)                                                      100        4,250          900         N.A.           470                 310
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Target MOE of 100 based on using UF of 10X for interspecies extrapolation and 10X for intraspecies variability.
\2\ MOE food + water, which incorporated the dietary exposures for treated crops, irrigated crops and aquatic uses, = ( short-term oral NOAEL)/(chronic
  dietary exposure). Short-term NOAEL = 9.4 mg/kg/day from the 2-generation reproduction rat study, chronic dietary (food+ water) exposure = 0.003395,
  Children 3-5 years old, and 0.002211, Adults 50+ years old.
\3\ MOE oral = (short-term oral NOAEL)/(Oral postapplication exposure of Swimmers) Short-term NOAEL = 9.4 mg/kg/day from the 2-generation reproduction
  rat study, Oral daily postapplication exposure of swimmers = 0.0341 mg/kg/day, Children 6-10 years old; 0.0107 mg/kg/day, Adults (see Table <IP_ADDRESS>).
\4\ MOE inhalation = [(inhalation NOAEL)/(high-end inhalation residential handler exposure)] Short-term inhalation NOAEL = 9.4 mg/kg/day from the 2-
  generation reproduction rat study.
\5\ Aggregate MOE (food + water and residential) = 1/[ [(1/MOE food+ water) + (1/MOE oral) + (1/MOE dermal) + (1/MOE inhalation)]]

    4. Intermediate-term risk. Due to the episodic residential use of
Endothall, no intermediate term aggregate (dietary + residential) risk
assessment was performed.
    5. Aggregate cancer risk for U.S. population. Endothall is
considered not likely to be carcinogenic to humans.
    6. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, and to infants and children from aggregate
exposure to endothall and its monomethyl ester residues.

IV. Other Considerations

A. Analytical Enforcement Methodology

    An improved high performance liquid chromotography-mass
spectrometry detection (HPLC-MSD) method has been submitted as a
confirmatory enforcement method for plants and fish. A gas
chromatography method with microcoulometric nitrogen detection is
listed as Method I in the Pesticide Analytical Manual (PAM, Volume II)
for the determination of endothall residues in/on crop commodities.
    Adequate enforcement methodology (specify method; example--gas
chromatography) is available to enforce the tolerance expression. The
method may be requested from: Chief, Analytical Chemistry Branch,
Environmental Science Center, 701 Mapes Rd., Ft. Meade, MD 20755-5350;
telephone number:<PHONE_NUMBER>; e-mail address:
<EMAIL_ADDRESS>

B. International Residue Limits

    No International tolerances have been set for endothall.

C. Response to Comments

    Public comments were received from B. Sachau who objected to the
proposed tolerances because of the amounts of pesticides already
consumed and carried by the American population. She further indicated
that testing conducted on animals have absolutely no validity and are
cruel to the test animals. B. Sachau's comments contained no scientific
data or evidence to rebut the Agency's conclusion that there is a
reasonable certainty that no harm will result from aggregate exposure
to endothall, including all anticipated dietary exposures and all other
exposures for which there is reliable information. EPA has responded to
B. Sachau's generalized comments on numerous previous occasions.

V. Conclusion

    Therefore, the tolerance is established for combined residues of
endothall, 7-oxabicyclo[2,2,1] heptane-2,3-dicarboxylic acid and its
monomethyl ester, in or on fish at 0.1 ppm, and the endothall tolerance
in 40 CFR 180.293 is revised to be expressed in terms of endothall per
se and its monomethyl ester.

VI. Statutory and Executive Order Reviews

    This final rule establishes a tolerance under section 408(d) of
FFDCA in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this rule has been
exempted from review under Executive Order 12866 due to its lack of
significance, this rule is not subject to Executive Order 13211,
Actions Concerning Regulations That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May 22, 2001). This final rule does
not contain any information collections subject to OMB approval under
the Paperwork Reduction Act (PRA), 44 U.S.C. 3501 et seq., or impose
any enforceable duty or contain any unfunded mandate as described under
Title II of the Unfunded Mandates Reform Act of 1995 (UMRA) (Public Law
104-4). Nor does it require any

special considerations under Executive Order 12898, entitled Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations (59 FR 7629, February 16, 1994); or OMB review
or any Agency action under Executive Order 13045, entitled Protection
of Children from Environmental Health Risks and Safety Risks (62 FR
19885, April 23, 1997). This action does not involve any technical
standards that would require Agency consideration of voluntary
consensus standards pursuant to section 12(d) of the National
Technology Transfer and Advancement Act of 1995 (NTTAA), Public Law
104-113, section 12(d) (15 U.S.C. 272 note). Since tolerances and
exemptions that are established on the basis of a petition under
section 408(d) of FFDCA, such as the tolerance in this final rule, do
not require the issuance of a proposed rule, the requirements of the
Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et seq.) do not apply.
The Agency hereby certifies that this rule will not have significant
negative economic impact on a substantial number of small entities. In
addition, the Agency has determined that this action will not have a
substantial direct effect on States, on the relationship between the
national government and the States, or on the distribution of power and
responsibilities among the various levels of government, as specified
in Executive Order 13132, entitled Federalism(64 FR 43255, August 10,
1999). Executive Order 13132 requires EPA to develop an accountable
process to ensure ``meaningful and timely input by State and local
officials in the development of regulatory policies that have
federalism implications.'' ``Policies that have federalism
implications'' is defined in the Executive order to include regulations
that have ``substantial direct effects on the States, on the
relationship between the national government and the States, or on the
distribution of power and responsibilities among the various levels of
government.'' This final rule directly regulates growers, food
processors, food handlers and food retailers, not States. This action
does not alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. For these same reasons, the Agency has
determined that this rule does not have any ``tribal implications'' as
described in Executive Order 13175, entitled Consultation and
Coordination with Indian Tribal Governments (65 FR 67249, November 6,
2000). Executive Order 13175, requires EPA to develop an accountable
process to ensure ``meaningful and timely input by tribal officials in
the development of regulatory policies that have tribal implications.''
``Policies that have tribal implications'' is defined in the Executive
order to include regulations that have ``substantial direct effects on
one or more Indian tribes, on the relationship between the Federal
Government and the Indian tribes, or on the distribution of power and
responsibilities between the Federal Government and Indian tribes.''
This rule will not have substantial direct effects on tribal
governments, on the relationship between the Federal Government and
Indian tribes, or on the distribution of power and responsibilities
between the Federal Government and Indian tribes, as specified in
Executive Order 13175. Thus, Executive Order 13175 does not apply to
this rule.

VII. Congressional Review Act

    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the
Small Business Regulatory Enforcement Fairness Act of 1996, generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report, which includes a copy of the rule,
to each House of the Congress and to the Comptroller General of the
United States. EPA will submit a report containing this rule and other
required information to the U.S. Senate, the U.S. House of
Representatives, and the Comptroller General of the United States prior
to publication of this final rule in the Federal Register. This final
rule is not a ``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.

    Dated: August 3, 2006.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.

0
Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

0
1. The authority citation for part 180 continues to read as follows:

    Authority: 21 U.S.C. 321(q), 346a and 371.

0
2. Section 180.293, paragraph (a)(1) is amended by revising the
introductory text and alphabetically adding the commodity ``fish'' to
the table to read as follows:

Sec.  180.293  Endothall; tolerances for residues.

    (a) General. (1) Tolerances are established for combined residues
of Endothall, 7-oxabicyclo [2, 2, 1] heptane-2, 3-dicarboxylic acid and
its monomethyl ester in or on the following raw agricultural
commodities:

------------------------------------------------------------------------
                      Commodity                        Parts per million
------------------------------------------------------------------------
                                * * * * *
Fish.................................................                0.1
                                * * * * *
------------------------------------------------------------------------

* * * * *
[FR Doc. E6-13293 Filed 8-15-06; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register Volume 84, Number 115 (Friday, June 14, 2019)]
[Notices]
[Pages 27774-27775]
[FR Doc No: 2019-12584]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 4678-052; Project No. 4679-049]

New York Power Authority; Notice of Intent To File License
Application, Filing of Pre-Application Document (PAD), Commencement of
Pre-Filing Process, and Scoping; Request for Comments on the Pad and
Scoping Document, and Identification of Issues and Associated Study
Requests

    a. Type of Filing: Notices of Intent to File License Applications
for New Licenses and Commencing Pre-filing Process.
    b. Project Nos.: 4678-052 and 4679-049.
    c. Dated Filed: May 3, 2019.
    d. Submitted By: New York Power Authority.
    e. Name of Project: Crescent Hydroelectric Project (P-4678-052) and
Vischer Ferry Hydroelectric Project (P-4679-049).
    f. Location: Both projects are located on the lower Mohawk River.
The Crescent Project is located at river mile 4 of the Mohawk River in
Saratoga, Albany, and Schenectady Counties, New York. The Vischer Ferry
Project is located at river mile 10 of the Mohawk River, in Albany and
Schenectady Counties, New York. The projects do not occupy federal
lands.
    g. Filed Pursuant to: 18 CFR part 5 of the Commission's
Regulations.
    h. Potential Applicant Contact: Tara Groom, New York Power
Authority, 30 South Pearl Street, Albany, NY 12207. Phone: (518) 433-
6748 or email at<EMAIL_ADDRESS>    i. FERC Contact: Jody Callihan at<PHONE_NUMBER> or email at
<EMAIL_ADDRESS>    j. Cooperating agencies: Federal, state, local, and tribal agencies
with jurisdiction and/or special expertise with respect to
environmental issues that wish to cooperate in the preparation of the
environmental document should follow the instructions for filing such
requests described in item o below. Cooperating agencies should note
the Commission's policy that agencies that cooperate in the preparation
of the environmental document cannot also intervene. See 94 FERC ]
61,076 (2001).
    k. With this notice, we are initiating informal consultation with:
(a) The U.S. Fish and Wildlife Service and/or NOAA Fisheries under
section 7 of the Endangered Species Act and the joint agency
regulations thereunder at 50 CFR, Part 402 and (b) the State Historic
Preservation Officer, as required by section 106, National Historic
Preservation Act, and the implementing regulations of the Advisory
Council on Historic Preservation at 36 CFR 800.2.
    l. With this notice, we are designating New York Power Authority as
the Commission's non-federal representative for carrying out informal
consultation, pursuant to section 7 of the Endangered Species Act and
section 106 of the National Historic Preservation Act.
    m. New York Power Authority filed with the Commission a Pre-
Application Document (PAD; including a proposed process plan and
schedule), pursuant to 18 CFR 5.6 of the Commission's regulations.
    n. A copy of the PAD is available for review at the Commission in
the Public Reference Room or may be viewed on the Commission's website
(http://www.ferc.gov), using the ``eLibrary'' link. Enter the docket
number, excluding the last three digits in the docket number field to
access the document. For assistance, contact FERC Online Support at
<EMAIL_ADDRESS>(866) 208-3676 (toll free), or (202) 502-
8659 (TTY). A copy is also available for inspection and reproduction at
the address in paragraph h.
    Register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filing and issuances
related to this or other pending projects. For assistance, contact FERC
Online Support.

    o. With this notice, we are soliciting comments on the PAD and
Commission's staff Scoping Document 1 (SD1), as well as study requests.
All comments on the PAD and SD1, and study requests should be sent to
the address above in paragraph h. In addition, all comments on the PAD
and SD1, study requests, requests for cooperating agency status, and
all communications to and from Commission staff related to the merits
of the potential application must be filed with the Commission.
    The Commission strongly encourages electronic filing. Please file
all documents using the Commission's eFiling system at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit brief
comments up to 6,000 characters, without prior registration, using the
eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You
must include your name and contact information at the end of your
comments. For assistance, please contact FERC Online Support at
[email protected] In lieu of electronic filing, please send a
paper copy to: Secretary, Federal Energy Regulatory Commission, 888
First Street NE, Washington, DC 20426. The first page of any filing
should include docket number P-4678-052 (for the Crescent Hydroelectric
Project) and/or P-4679-049 (for the Vischer Ferry Hydroelectric
Project).
    All filings with the Commission must bear the appropriate heading:
``Comments on Pre-Application Document,'' ``Study Requests,''
``Comments on Scoping Document 1,'' ``Request for Cooperating Agency
Status,'' or ``Communications to and from Commission Staff.'' Any
individual or entity interested in submitting study requests,
commenting on the PAD or SD1, and any agency requesting cooperating
status must do so by August 9, 2019.
    p. Although our current intent is to prepare an environmental
assessment (EA), there is the possibility that an Environmental Impact
Statement (EIS) will be required. Nevertheless, this meeting will
satisfy the NEPA scoping requirements, irrespective of whether an EA or
EIS is issued by the Commission.

Scoping Meetings

    Commission staff will hold two scoping meetings in the vicinity of
the projects at the times and places noted below. The daytime meeting
will focus on resource agency, Indian tribes, and non-governmental
organization concerns, while the evening meeting is primarily for
receiving input from the public. We invite all interested individuals,
organizations, and agencies to attend one or both of the meetings, and
to assist staff in identifying particular study needs, as well as the
scope of environmental issues to be addressed in the environmental
document. The times and locations of these meetings are as follows:

Evening Scoping Meeting

    Date: Wednesday, July 10, 2019.
    Time: 7:00 p.m.
    Location: Hilton Garden Inn (Whitney/Travers Room), 30 Clifton
Country Road, Clifton Park, New York, 12065.
    Phone:<PHONE_NUMBER>.

Daytime Scoping Meeting

    Date: Thursday, July 11, 2019.
    Time: 9:00 a.m.
    Location: Hilton Garden Inn (Whitney/Travers Room), 30 Clifton
Country Road, Clifton Park, New York, 12065.
    Phone:<PHONE_NUMBER>.
    Scoping Document 1 (SD1), which outlines the subject areas to be
addressed in the environmental document, was mailed to the individuals
and entities on the Commission's mailing list. Copies of SD1 will be
available at the scoping meetings, or may be viewed on the web at
http://www.ferc.gov, using the ``eLibrary'' link. Follow the directions
for accessing information in paragraph n. Based on all oral and written
comments, a Scoping Document 2 (SD2) may be issued. SD2 may include a
revised process plan and schedule, as well as a list of issues,
identified through the scoping process.

Environmental Site Review

    The potential applicant and Commission staff will conduct site
visits of the projects on Wednesday, July 10, 2019, starting at 9:30
a.m. All participants should meet in the parking lot of the Crescent
Hydroelectric Project, located at 60 Cohoes Crescent Rd., Cohoes, NY
12047 (Latitude 42.8056/Longitude-73.7227. We will conduct the site
visit for the Vischer Ferry Hydroelectric Project after the Crescent
Project site visit. All participants are responsible for their own
transportation. Anyone with questions about the site visits should
contact Tara Groom of the New York State Power Authority at (518) 433-
6748.

Meeting Objectives

    At the scoping meetings, staff will: (1) Initiate scoping of the
issues; (2) review and discuss existing conditions and resource
management objectives; (3) review and discuss existing information and
identify preliminary information and study needs; (4) review and
discuss the process plan and schedule for pre-filing activity that
incorporates the time frames provided for in Part 5 of the Commission's
regulations and, to the extent possible, maximizes coordination of
federal, state, and tribal permitting and certification processes; and
(5) discuss the appropriateness of any federal or state agency or
Indian tribe acting as a cooperating agency for development of an
environmental document.
    Meeting participants should come prepared to discuss their issues
and/or concerns. Please review the PAD in preparation for the scoping
meetings. Directions on how to obtain a copy of the PAD and SD1 are
included in item n. of this document.

Meeting Procedures

    The meetings will be recorded by a stenographer and will be placed
in the public records of the projects.

    Dated: June 10, 2019.
Kimberly D. Bose,
Secretary.
[FR Doc. 2019-12584 Filed 6-13-19; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 80, Number 125 (Tuesday, June 30, 2015)]
[Notices]
[Pages 37270-37273]
[FR Doc No: 2015-16020]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-2126]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Evaluation of the Food and Drug Administration's
Campaign To Reduce Tobacco Use Among Lesbian, Gay, Bisexual, and
Transgender Young Adults

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish a notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on

the Evaluation of FDA's Multicultural Youth Tobacco Prevention
Campaigns.

DATES: Submit either electronic or written comments on the collection
of information by August 31, 2015.

ADDRESSES: Submit electronic comments on the collection of information
to http://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information before
submitting the collection to OMB for approval. To comply with this
requirement, FDA is publishing notice of the proposed collection of
information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Evaluation of FDA's Campaign To Reduce Tobacco Use Among Lesbian, Gay,
Bisexual, and Transgender Young Adults OMB Control Number--0910-New

    The 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco
Control Act) (Pub. L. 111-31) amends the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) to grant FDA authority to regulate the
manufacture, marketing, and distribution of tobacco products to protect
public health and to reduce tobacco use by minors. Section
1003(d)(2)(D) of the FD&C Act (21 U.S.C. 393(d)(2)(D)) supports the
development and implementation of FDA public education campaigns
related to tobacco use. Accordingly, FDA is currently developing and
implementing public education campaigns to help prevent and reduce
tobacco use among lesbian, gay, bisexual and transgender (LGBT) young
adults and thereby reduce the public health burden of tobacco. Overall
the campaigns will feature events; advertisements on television and
radio and in print; digital communications including social media; and
other forms of media.
    In support of the provisions of the Tobacco Control Act that
require FDA to protect the public health and to reduce tobacco use, FDA
requests OMB approval to collect information needed to evaluate FDA's
campaign to reduce tobacco use among LGBT young adults. Comprehensive
evaluation of FDA's public education campaigns is needed to ensure
campaign messages are effectively received, understood, and accepted by
those for whom they are intended. Evaluation is an essential
organizational practice in public health and a systematic way to
account for and improve public health actions.
    FDA plans to conduct two studies to evaluate the effectiveness of
its LGBT young adult tobacco prevention campaign: (1) An outcome
evaluation study to evaluate the effectiveness of its LGBT young adult
tobacco prevention campaign, and (2) a media tracking questionnaire to
assess awareness of and receptivity to campaign messages. The timing of
these studies will be designed to follow the multiple, discrete waves
of media advertising planned for the campaigns.
 Outcome Evaluation Study
    The outcome evaluation study begins with a baseline survey of LGBT
young adults aged 18 to 24 before the campaign launch. The baseline
will be followed by three follow-up surveys of the target audience of
young adults at approximately 6-month intervals after the campaign's
launch. Information will be collected about young adult awareness of
and exposure to campaign events and advertisements and about tobacco-
related knowledge, attitudes, beliefs, intentions and use, as well as
use of other tobacco products (e-cigarettes, hookah, cigars, smokeless
tobacco), marijuana and alcohol. Information will also be collected on
demographic variables including sexual orientation, age, sex, race/
ethnicity, education, and primary language.
    All information will be collected through in-person and web-based
questionnaires. Young adult respondents will be recruited in 30 U.S.
cities (15 campaign and 15 comparison cities) from two sources: (1)
Intercept surveys in LGBT social venues (e.g., bars and nightclubs)
identified using a time location sampling approach, and (2) through
social media advertisements on Facebook and Twitter targeted at LGBT 18
to 24-year-olds, living in the same 30 U.S. cities. Participation in
the study is voluntary.
 Media Tracking Survey
    The media tracking survey consists of assessments of LGBT young
adults aged 18 to 24 conducted once yearly post campaign launch--timing
that complements the outcome evaluation's timing. The media tracking
survey will assess awareness of the campaign and receptivity to
campaign messages. These data will provide critical evaluation feedback
to the campaigns and will be conducted with sufficient frequency to
match the cyclical patterns of events and media advertising and
variation in exposure to allow for mid-campaign refinements. For the
media tracking surveys, we will recruit LGBT young adults aged 18 to 24
from all campaign cities through social media.
    The information collected is necessary to inform FDA's efforts and
measure the effectiveness and public health impact of the campaigns.
Data from the media tracking surveys will be used to estimate awareness
of and exposure to the campaigns among young adults in target markets
where the campaigns are active. Data from the outcome evaluation study
will be used to examine statistical associations between awareness of
and exposure to the campaigns and subsequent changes in specific
outcomes of interest, which will include knowledge, attitudes, beliefs
and intentions related to tobacco use.
    FDA's burden estimate is based on prior experience with in-person
studies similar to the Agency's plan presented in this document, as
well as previous

research using social media advertising to recruit young adult
participants. To reduce overall burden hours, participants who screen
and complete the baseline outcome evaluation questionnaire will be re-
contacted to complete the first follow up campaign evaluation
questionnaire, those who complete the first follow up campaign
evaluation questionnaire will be re-contacted to complete the second
follow up campaign evaluation questionnaire, and so on. Re-contacted
individuals will not need to complete the screener again. We expect a
50 percent response rate for individuals recruited in person and a 30
percent rate for individuals recruited via social media. In each
successive round of data collection, we expect 50 percent of re-
contacted individuals to complete the follow up questionnaire,
therefore, additional screenings will be conducted for each follow up
in order to maintain the target sample size for each follow up
questionnaire.
    To obtain the target number of completed questionnaires
(``completes'') for the outcome evaluation study, 18,376 young adults
(11,810 recruited in person and 6,566 recruited via social media) will
participate in a screening process (``screener''). The estimated burden
per screener is 5 minutes (0.083), for a total of 1,525 hours (980
hours for participants recruited in person and 545 hours for persons
recruited via social media). A total of 12,600 LGBT young adults (9,448
of those screened in person and 3,152 of those screened through social
media) will complete questionnaires in 4 rounds of data collection
(baseline and three post-campaign rounds). The estimated burden per
complete is 30 minutes (0.5 hour) for the baseline questionnaire and 40
minutes (0.667 hour) for each follow up complete, for a total of 7,878
hours (5,906 hours for those recruited in person and 1,972 hours for
those recruited via social media).
    To obtain the target number of completes for the media tracking
survey, 5,000 young adults will be recruited via social media ads to
complete a screener for all three waves of the media tracking survey.
The estimated burden per screener response is 5 minutes (0.083 hour),
for a total of 414 hours for all waves of media tracking screener. An
estimated 500 LGBT young adults will complete each of the three waves
of the media tracking survey (assuming a 30 percent response rate to
screeners via social media). The estimated burden per completed media
tracking questionnaire is 40 minutes (0.667 hour), for a total of 1,002
hours for the three waves. The total burden for the media tracking
survey (screeners and completes) is 1,416 hours.
    The target number of completed campaign questionnaires (screeners
and questionnaires for both the outcome evaluation and media tracking
survey) for all respondents is 37,477. The total estimated burden is
10,819 hours.

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                               Number of
         Type of respondent                 Activity           Number of     responses per   Total annual        Average  burden per        Total hours
                                                              respondents     respondent       responses              response
--------------------------------------------------------------------------------------------------------------------------------------------------------
General population--Recruited in     Screener--Baseline--o           4,724               1           4,724  0.083 (5 min.)..............             392
 person (50% response rate).          utcome study.
                                     Screener--First                 2,362               1           2,362  0.083 (5 min.)..............             196
                                      follow up--outcome
                                      study.
                                     Screener--Second                2,362               1           2,362  0.083 (5 min.)..............             196
                                      follow up--outcome
                                      study.
                                     Screener--Third                 2,362               1           2,362  0.083 (5 min.)..............             196
                                      follow up--outcome
                                      study.
LGBT young adults aged 18-24 in      Baseline--outcome               2,362               1           2,362  0.5 (30 min.)...............            1181
 select media markets--Recruited in   evaluation
 person.                              questionnaire.
                                     First follow up young           2,362               1           2,362  0.667 (40 min.).............            1575
                                      adult outcome
                                      evaluation
                                      questionnaire.
                                     Second follow up                2,362               1           2,362  0.667 (40 min.).............            1575
                                      young adult outcome
                                      evaluation
                                      questionnaire.
                                     Third follow up young           2,362               1           2,362  0.667 (40 min.).............            1575
                                      adult outcome
                                      evaluation
                                      questionnaire.
General population--Recruited via    Screener--Baseline--o           2,627               1           2,627  0.083 (5 min.)..............             218
 social media (30% response rate).    utcome study.
                                     Screener--First                 1,313               1           1,313  0.083 (5 min.)..............             109
                                      follow up--outcome
                                      study.
                                     Screener--Second                1,313               1           1,313  0.083 (5 min.)..............             109
                                      follow up--outcome
                                      study.
                                     Screener--Third                 1,313               1           1,313  0.083 (5 min.)..............             109
                                      follow up--outcome
                                      study.
LGBT young adults aged 18-24 in      Baseline--outcome                 788               1             788  0.5 (30 min.)...............             394
 select media markets--Recruited      evaluation
 via social media.                    questionnaire.
                                     First follow up young             788               1             788  0.667 (40 min.).............             526
                                      adult outcome
                                      evaluation
                                      questionnaire.

                                     Second follow up                  788               1             788  0.667 (40 min.).............             526
                                      young adult outcome
                                      evaluation
                                      questionnaire.
                                     Third follow up young             788               1             788  0.667 (40 min.).............             526
                                      adult outcome
                                      evaluation
                                      questionnaire.
LGBT young adults aged 18-24 in the  1st media tracking               1667               1            1667  0.083 (5 min.)..............             138
 select media markets--Recruited      screener.
 via social media.
                                     1st media tracking                500               1             500  0.667 (40 min.).............             334
                                      questionnaire.
                                     2nd media tracking               1667               1            1667  0.083 (5 min.)..............             138
                                      screener.
                                     2nd media tracking                500               1             500  0.667 (40 min.).............             334
                                      questionnaire.
                                     3rd media tracking               1667               1            1667  0.083 (5 min.)..............             138
                                      screener.
                                     3rd media tracking                500               1             500  0.667 (40 min.).............             334
                                      questionnaire.
                                                           ------------------------------------------------                              ---------------
    Total..........................  .....................          37,477  ..............  ..............  ............................          10,819
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Dated: June 24, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-16020 Filed 6-29-15; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register: May 10, 2007 (Volume 72, Number 90)]
[Notices]
[Page 26616]
[DOCID:fr10my07-53]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP07-427-000]

Gulfstream Natural Gas System, L.L.C.; Notice of Proposed Changes
in FERC Gas Tariff

May 3, 2007.
    Take notice that on May 1, 2007, Gulfstream Natural Gas System,
L.L.C. (Gulfstream) tendered for filing as part of its FERC Gas Tariff,
Original Volume No. 1, Sixth Revised Sheet No. 7, with an effective
date of June 1, 2007.
    Gulfstream states that copies of its filing have been mailed to all
affected customers and interested state commissions.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Sec.  154.210 of the Commission's regulations (18 CFR 154.210). Anyone
filing an intervention or protest must serve a copy of that document on
the Applicant. Anyone filing an intervention or protest on or before
the intervention or protest date need not serve motions to intervene or
protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-8934 Filed 5-9-07; 8:45 am]

BILLING CODE 6717-01-P